Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study

被引:81
作者
Badri, Motasim [1 ]
D Lawn, Stephen
Wood, Robin
机构
[1] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa
[2] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Clin Res Unit, London WC1, England
基金
英国惠康基金;
关键词
D O I
10.1016/S0140-6736(06)69117-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In sub-Saharan Africa, data for short-term risk of AIDS or death, which might inform decisions about when to start antiretroviral therapy (ART), are scarce. Our aim was to investigate these risks in patients who had no access to ART or who were given zidovudine alone. Methods 6-month risks (%) of death, AIDS, and combined risk of AIDS and death (AIDS/death) were calculated according to CD4-cell count category of less than 200 cells per mu L, 200-350 cells per mu L, or greater than 350 cells per mu L, stratified by WHO clinical stages I and 2 combined, 3, or 4 in untreated patients (n=1399) seeking care in tertiary public-sector HIV clinics before widespread availability of ART in Cape Town, South Africa. Findings Risk of death for WHO stages 1 and 2 was 3.5% for those with less than 200 cells per mu L, 2.8% for 200-350 cells per mu L, and 1.2% for greater than 350 cells per mu L. The corresponding rates for WHO stage 3 were 10.8%, 4.3%, and 4.9% and for stage 4, 22.2%, 10.3%, and 13.8%. 52% (90) of deaths took place in patients without AIDS. 6-month risk of AIDS for WHO stages 1 and 2 was 3.5% for those with less than 200 cells per mu L, 1.6% for 200-350 cells per mu L, and zero for greater than 350 cells per mu L. The corresponding rates for those with WHO stage 3 disease were 17.4%, 7.0%, and 2.2%. Interpretation In this study, risk of AIDS in patients with a CD4-cell count of less than 200 cells per mu L or greater than 350 cells per mu L was similar to that previously reported from European cohorts, but was 1.9 times greater for those with CD4-cell counts of between 200 and 350 cells per mu L. The high death rate before development of AIDS and a high risk of AIDS in those with CD4-cell counts of 200-350 cells per mu L indicate that delay in initiation of ART is associated with increased morbidity and mortality. These findings might help to amend criteria for start of ART in resource-limited settings.
引用
收藏
页码:1254 / 1259
页数:6
相关论文
共 34 条
[11]  
Cleary S, 2004, COST EFFECTIVENESS A
[12]   SEROCONVERSION RATE, MORTALITY, AND CLINICAL MANIFESTATIONS ASSOCIATED WITH THE RECEIPT OF A HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED BLOOD-TRANSFUSION IN KINSHASA, ZAIRE [J].
COLEBUNDERS, R ;
RYDER, R ;
FRANCIS, H ;
NEKWEI, W ;
BAHWE, Y ;
LEBUGHE, I ;
NDILU, M ;
VERCAUTEREN, G ;
NSEKA, K ;
PERRIENS, J ;
VANDERSTUYFT, P ;
QUINN, TC ;
PIOT, P .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03) :450-456
[13]   AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion [J].
deWolf, F ;
Spijkerman, I ;
Schellekens, PT ;
Langendam, M ;
Kuiken, C ;
Bakker, M ;
Roos, M ;
Coutinho, R ;
Miedema, F ;
Goudsmit, J .
AIDS, 1997, 11 (15) :1799-1806
[14]   Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design [J].
Lawn, SD ;
Myer, L ;
Orrell, C ;
Bekker, LG ;
Wood, R .
AIDS, 2005, 19 (18) :2141-2148
[15]   The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection [J].
Lepri, AC ;
Katzenstein, TL ;
Ullum, H ;
Phillips, AN ;
Skinhoj, P ;
Gerstoft, J ;
Pedersen, BK .
AIDS, 1998, 12 (13) :1639-1643
[16]   PREDICTORS OF MORTALITY AMONG HIV-INFECTED WOMEN IN KIGALI, RWANDA [J].
LINDAN, CP ;
ALLEN, S ;
SERUFILIRA, A ;
LIFSON, AR ;
VANDEPERRE, P ;
CHENRUNDLE, A ;
BATUNGWANAYO, J ;
NSENGUMUREMYI, F ;
BOGAERTS, J ;
HULLEY, S .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (04) :320-328
[17]   The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda [J].
Malamba, SS ;
Morgan, D ;
Clayton, T ;
Mayanja, B ;
Okongo, M ;
Whitworth, J .
AIDS, 1999, 13 (18) :2555-2562
[18]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170
[19]   Plasma viral load and CD4(+) lymphocytes as prognostic markers of HIV-1 infection [J].
Mellors, JW ;
Munoz, A ;
Giorgi, JV ;
Margolick, JB ;
Tassoni, CJ ;
Gupta, P ;
Kingsley, LA ;
Todd, JA ;
Saah, AJ ;
Detels, R ;
Phair, JP ;
Rinaldo, CR .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :946-954
[20]   HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? [J].
Morgan, D ;
Mahe, C ;
Mayanja, B ;
Okongo, JM ;
Lubega, R ;
Whitworth, JAG .
AIDS, 2002, 16 (04) :597-603